Reckitt Benckiser Puts Mucinex Up for Review
Posted in: Uncategorized
Reckitt Benckiser has added Mucinex to the list of brands for which it is reviewing creative duties, Ad Age has learned. This could mean an end to the repulsive Mr. Mucus and his clan who’ve starred in the brand’s ads.
A Reckitt Benckiser spokesman declined to comment on the reviews or whether they had to do with market performance of the brands involved. Reviews for Air Wick and Finish are still ongoing.
Mucinex has been RB’s top focus from an advertising perspective in recent years, according to Kantar Media data, reaching $92 million in measured media in 2012, but spending fell to $57 million last year. Mucinex has handled advertising in-house both before and after RB’s 2007 acquisition of the brand along with the rest of Adams Respiratory Therapeutics.
Post a Comment